Penehyclidine for Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Gynecological Laparoscopic Surgery Under Combined Intravenous and Inhalation Anesthesia: A Randomized, Double-Blind, Placebo-Controlled Trial
Kai Zhao,Yali Gao,Jianping Zhang,Shan Wang,Jiaqi Chen,Fenglin Guo,Sheng Wang
DOI: https://doi.org/10.2147/dddt.s453327
IF: 4.3188
2024-03-02
Drug Design Development and Therapy
Abstract:Kai Zhao, 1, 2 Yali Gao, 1, 2 Jianping Zhang, 1, 2 Shan Wang, 1, 2 Jiaqi Chen, 1, 2 Fenglin Guo, 1, 2, &ast Sheng Wang 1, 2, &ast 1 Department of Anesthesiology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China (USTC), Hefei, Anhui, People's Republic of China; 2 Department of Anesthesiology, Anhui Provincial Hospital, Hefei, Anhui, People's Republic of China &astThese authors contributed equally to this work Correspondence: Fenglin Guo; Sheng Wang, Department of Anesthesiology, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, People's Republic of China, Tel +86 15395006763 ; +86 19156007726, Email ; Purpose: We designed this study to investigate the effect of intravenous use of penehyclidine on postoperative nausea and vomiting (PONV) after gynecological laparoscopic surgery. Patients and Methods: Ninety-two Women Patients (Aged ≥ 18) Scheduled for Elective Gynecologic Laparoscopy Were Enrolled in the Current Study. Patients Were Equally Randomized Assigned Into Penehyclidine group (PHC group: received a bolus of penehyclidine 10 μg/kg during the induction of anesthesia, then followed by a continuous infusion of 10 μg/kg penehyclidine at a fixed rate of 2.0 mL/h in postoperative intravenous analgesia pump over 48h, 0.5 mg upper limit respectively) or Control group (received 0.9% saline in replace of penehyclidine at the same time points). The primary outcome measure was the incidence of postoperative nausea and vomiting in the postanesthesia care unit and ward area. Quality of Recovery-15 (QoR-15) scores and general comfort questionnaire (GCQ) scores were assessed on postoperative day (POD) 1, 2. Results: Patients between two groups had comparable baseline characteristics. Compared with the Control group, the incidence and severity of PONV, postoperative nausea (PON), and postoperative vomiting (POV) were significantly lower in the PHC group at 2h (PONV: P = 0.002, P = 0.004, respectively; PON: P = 0.018, P = 0.038, respectively; POV: P = 0.011, P = 0.072, respectively), 24h (PONV: P = 0.003, P = 0.001, respectively; PON: P = 0.010, P = 0.032, respectively; POV: P = 0.006, P = 0.044, respectively), and 48h (PONV: P = 0.003, P = 0.002, respectively; PON: P = 0.007, P = 0.019, respectively; POV: P = 0.002, P = 0.013, respectively) after surgery. The QoR-15 and GCQ scores of the PHC group were significantly higher than those of the Control group at POD 1, 2 ( P < 0.001; P < 0.001, respectively). Conclusion: Our findings suggest that perioperative intravenous application of penehyclidine can effectively prevent postoperative nausea and vomiting in gynecological laparoscopic surgery patients and improve postoperative recovery. Keywords: penehyclidine, gynecologic laparoscopy, postoperative nausea and vomiting, quality of recovery Postoperative nausea and vomiting is a common complication after general anesthesia, the incidence of which is about 30% in all surgical types, 1,2 and the prevention and management of PONV are not very satisfactory. Previous studies have shown that some factors may increase the risk of PONV, such as female sex, a history of motion sickness or previous PONV, use of opioids, a significantly long duration of surgery, and non-smoking status. 3,4 In certain types of surgery, such as gynecological laparoscopic surgery in high-risk patients, the incidence of PONV is as high as 80%. 5–7 In addition to the above factors that may increase the incidence of PONV, the establishment of artificial pneumoperitoneum, use of inhaled anesthetics and surgical operations are likely to cause a significant increase in the incidence of PONV. PONV is likely to cause wound cracking, aggravate postoperative pain, delay postoperative recovery, prolong hospital stay, and reduce patient comfort and satisfaction. Vomiting is a complex neural reflex that activates the sensation of vomiting through receptors such as cholinergic (muscarine), dopaminergic, histamine, or 5-serotonergic receptors when the afferent pathway is stimulated. 8 Despite advances in prevention and treatment, it is still impossible to effectively prevent and control the occurrence of PONV in clinic, especially most patients undergoing gynecolog -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal